drugset / Trial / NCT00818090
Paclitaxel and Cisplatin for Thymic Neoplasm
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the efficacy and safety of the regimen in previously untreated, unresectable invasive thymoma or thymic carcinoma
Timeline
- Start
- 2008-09
- Primary completion
- 2011-11
- Completion
- 2011-11
Outcome
Outcome not reported
Stopped: “marginal statistical significance”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | Paclitaxel | Small molecule | — | — |